Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04588272
Other study ID # Non invasive EtCO2 monitoring.
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2020
Est. completion date December 1, 2021

Study information

Verified date March 2022
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

CO2 monitoring through non-invasive methods at different O2 flow rates may provide an early warning sign of hypoventilation during procedural sedation.


Description:

Sedation is a drug-induced depression in the level of consciousness. The clinical objectives of administering sedation for GI endoscopy are to relieve patient anxiety and discomfort, improve the outcome of the examination, and diminish the patient's memory of the event. A number of different sedatives and analgesics can be used to achieve appropriate levels of sedation for GI endoscopic procedures. The targeted level of sedation may vary depending on patient and procedural variables, and doses of sedatives should be titrated accordingly to achieve a safe, comfortable, and technically successful endoscopic procedure. Knowledge of the pharmacologic profiles of sedation agents is necessary to maximize the likelihood that the desired level of sedation is achieved.(1) All patients receiving sedation to facilitate endoscopic procedures should have monitoring of cardiorespiratory parameters before, during, and after administration of sedation/analgesia. Electronic monitoring may detect early signs of patient distress and is an adjunct to continuous clinical assessment. Commonly used monitoring equipment for patients undergoing endoscopic procedures includes pulse oximetry, single-lead continuous electrocardiographic (ECG) monitoring, and automated blood pressure monitoring. With the increased use of propofol to facilitate endoscopy in recent years, less familiar monitoring devices have been introduced, including end-tidal carbon dioxide (EtCO2) and level of consciousness monitors. Given a recent change in the American Society of Anesthesiologists (ASA) guidelines, recommending CO2 monitoring for patients undergoing both moderate and deep sedation, familiarity with capnography may become necessary.(2) Patients are at risk of respiratory depression and acute hypercapnia during sedation and recovery from anaesthesia . Desaturation on pulse oximetry for monitoring of hypoventilation is a late sign. Moreover, hypoventilation is masked by administration of supplemental O2. ( 3) For a sedated patient in spontaneous ventilation, hypoventilation (by airway obstruction or central respiratory depression) will likely precede hypoxemia. Hence, if the patient is monitored using a capnograph machine, when hypoventilation occurs, PEtCO2 increases and the shape of the capnography curve is modified.This may trigger an adequate response from the person monitoring the anesthesia (chin thrust, sedative dose modification, oxygen supplementation) so as to prevent hypoxemia. (5) Measuring CO2 noninvasively includes capnography and capnometry. capnography provides numerical and graphical (waveforms) forms, while capnometry provides only numerical form. (6) Arterial blood gas (ABG) can tell us about the patient's acid-base balance, which is measured by the hydrogen ion (H) concentration in the blood (pH), oxygen saturation (SaO2), partial pressure of oxygen (PaO2), partial pressure of carbon dioxide (PaCO2), concentration of bicarbonate (HCO3), base excess and base deficit.(7) ABG results can indicate how effectively the patient's body is compensating for the acid-base disturbance and whether the patient's total blood volume is adequate for transporting all the nutrients that the body's tissues require. (8) Hyopthesis of this trial: is CO2 monitoring through non-invasive methods may provide an early warning sign of hypoventilation during procedural sedation. Primary outcome: Measuring end-tidal carbon dioxide (EtCO2) that is taken during different flows of oxygen(O2) supplementation. Secondary outcome: Will include O2 saturation, haemodynamics (systolic blood pressure, diastolic blood pressure and mean blood pressure), time to recovery, patient satisfaction, Ramsay sedation scale (which is used to measure level of sedation through dividing patients level of sedation into 6 categories ranging from severe agitation to deep coma). (9) Ramsay Sedation Scale 1. Patient is anxious and agitated or restless, or both. 2. Patient is co-operative, oriented, and tranquil. 3. Patient responds to commands only. 4. Patient exhibits brisk response to light glabellar tap or loud auditory stimulus. 5. Patient exhibits a sluggish response to light glabellar tap or loud auditory stimulus. 6. Patient exhibits no response.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date December 1, 2021
Est. primary completion date December 1, 2021
Accepts healthy volunteers No
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria: - Age: Adult Patients aged 20-60 years. - Sex: either male or female. - ASA physical status I or II. - Elective ERCP Exclusion Criteria: - Abnormal renal function test. - History of asthma or COPD - patients with a history of hypertension and diabetes. - Cardiac patients.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
DualGuard
DualGuard device (FlexiCare) which incorporate an endoscopy bite block with oxygen delivery and CO2 monitoring from both the mouth and nose simultaneously.

Locations

Country Name City State
Egypt Assiut university Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary End-tidal carbon dioxide : end-tidal carbon dioxide (EtCO2) that is taken during different flows of oxygen(O2) supplementation will be measured. During the procedure.
Secondary Oxygen saturation. : Measuring O2 saturation at different O2 flow rates. During the procedure.
Secondary Haemodynamics as blood pressure. Measuring systolic blood pressure, diastolic blood pressure and mean blood pressure. During the procedure.
See also
  Status Clinical Trial Phase
Completed NCT01686984 - Influence of Inspiratory Flow Pattern on Exchange of Carbon Dioxide in Humans Without Primary Lung Disease N/A
Completed NCT04879875 - New Method for Real-time Detection of Tissue Ischemia (ISCALERT) N/A
Completed NCT02563132 - Carbon Dioxide Insufflation Colonoscopy in IBD Patients N/A
Completed NCT00520416 - Prospective, Non-Randomized Evaluation of Carbon Dioxide Gas as a Contrast Agent in Comparison With Iodinated Contrast in Endovascular Aneurysm Repair N/A
Recruiting NCT04445909 - Validation of Continuous Transcutaneous Carbon Dioxide Monitoring in VA-ECMO Patients
Completed NCT05114993 - The Effect of Wearing Masks on End-tidal Carbon Dioxide and Pulse Oximetry N/A
Recruiting NCT05297266 - Early Discovery of Ischemia After Replantation Surgery of the Extremities N/A
Withdrawn NCT04893473 - New Method for Real-time Detection of Tissue Ischemia
Recruiting NCT04548687 - a Randomized Clinical Trial Evaluating the Effectiveness of Carbon Dioxide Use in Cardiac Surgery N/A
Recruiting NCT05051397 - CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke Phase 2
Recruiting NCT02032355 - The Feasibility of PetCO2 Prediction Hypotension Under Spinal Anesthesia for Cesarean Section N/A
Completed NCT04761237 - The Value of Central Venous-arterial Carbon Dioxide Difference N/A
Not yet recruiting NCT06079255 - Ischemia Detection During Development of Acute Compartment Syndrome
Completed NCT05497375 - EtCO2 Level to Control Intraoperative Bleeding and Improve the Quality of Surgical Field Vision in Septorhinoplasty N/A